Imaflex Reports Q3 2025 Results; Provides Business Update

Executive Summary

• Imaflex Inc. reported Q3 2025 revenue of C$27.5 M, a 3.3% decline versus the prior year, and adjusted net income of C$0.8 M, down 56% YoY.
• Adjusted EBITDA fell to C$3.1 M (11.2% of sales), also lower than the C$3.3 M reported in Q3 2024.
• Liquidity remains solid with C$23.9 M available at quarter‑end, including C$11.9 M cash and an undrawn C$12.0 M revolving credit facility.

Key Details

• Revenue: C$27.486 M (Q3 2025) vs. C$28.418 M (Q3 2024); Y/Y –3.3%.
• Gross Profit: C$4.359 M (–5.6% YoY). Gross margin 15.9% vs. 16.2% prior year.
• Selling & Administrative Expenses: C$2.889 M, up 10.8% YoY; expense ratio 10.5% of revenue.
• Other (gains) / losses: C$0.270 M, down 20.6% YoY. Year‑to‑date other loss of C$3.493 M vs. a gain of C$0.457 M in 2024, driven by cyber‑incident costs and FX impacts.
• Net Income: C$0.558 M (–62.0% YoY). Adjusted net income C$0.775 M (–56.1% YoY).
• Adjusted EBITDA: C$3.091 M (–7.4% YoY); margin 11.2% vs. 11.7% prior year.
• Liquidity: Total available liquidity C$23.9 M; cash balance C$11.9 M (up from C$9.0 M end‑2024) and undrawn revolving line of credit C$12.0 M.
• Working Capital: C$25.1 M at September 30, 2025 vs. C$23.4 M year‑end 2024.
• Cash from Operations: Q3 2025 net cash generated C$2.6 M (down from C$5.0 M YoY); YTD C$7.5 M vs. C$9.1 M prior year.
• Outlook: Management cautiously optimistic for Q4 2025 and 2026, citing improving market fundamentals, new production equipment expected to boost efficiency in 2026, and supportive USMCA trade environment.

Notable Quotes

“Market conditions remained challenging… targeted pricing and product mix initiatives helped stabilize top‑line performance… we are cautiously optimistic these positive trends will carry through the fourth quarter and into 2026.” – Stephan Yazedjian, President & CEO

Materiality Assessment: Material – Negative (significant revenue and earnings declines, but still material to investors).